
Please try another search
Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. The company also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix Hosted, which offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration, which supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform for drug discovery teams and their external collaborators; Certara D360 software, a scientific informatics system for small molecule and biologics discovery research; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and assembles regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.
Name | Age | Since | Title |
---|---|---|---|
Malcolm Rowland | - | - | Chair of Simcyp Scientific Advisory Board |
Donald E. Mager | - | - | Member of Simcyp Scientific Advisory Board |
Yuichi Sugiyama | - | - | Member of Simcyp Scientific Advisory Board |
J Brian Houston | - | - | Member of Simcyp Scientific Advisory Board |
Geoff Tucker | - | - | Member of Simcyp Scientific Advisory Board |
Lawrence J. Lesko | - | 2015 | Member of Simcyp Scientific Advisory Board |
Stephen M. McLean | - | 2013 | Independent Director |
Jennifer B. Dressman | - | 2017 | Member of Simcyp Scientific Advisory Board |
Noriko Okudaira | - | 2019 | Senior Consultant & Member of Simcyp Scientific Advisor Board |
William F. Feehery | 54 | 2019 | CEO & Director |
Matthew M. Walsh | 58 | 2020 | Independent Director |
James E. Cashman | 71 | 2018 | Independent Chairman of the Board |
Nancy Killefer | 72 | 2021 | Independent Director |
Cynthia L. Collins | 67 | 2021 | Independent Director |
David Spaight | 65 | 2022 | Independent Director |
Eran Broshy | 65 | 2022 | Independent Director |
Rosemary A. Crane | 65 | 2022 | Independent Director |
John V. W. Reynders | - | 2024 | Independent Director |
Frederic Yves Bois | - | 2019 | Senior Scientific Advisor, Head of Mechanistic Modeling & Member of Simcyp Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review